• Je něco špatně v tomto záznamu ?

Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities

G. Gastaldi, F. Pannier, K. Roztočil, M. Lugli, A. Mansilha, H. Haller, E. Rabe, MJ. VAN Rijn

. 2021 ; 40 (6) : 457-469. [pub] 20210922

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003102

Chronic venous disease and diabetes mellitus are highly prevalent and debilitating conditions affecting millions of individuals globally. Although these conditions are typically considered as separate entities, they often co-exist which may be important in both understanding their pathophysiology and determining the best treatment strategy. Diabetes mellitus is twice as common in patients with chronic venous disease compared with the general population. Notably, a large proportion of patients with diabetes mellitus present with venous disorders, although this is often overlooked. The etiology of chronic venous disease is multifactorial, involving hemodynamic, genetic, and environmental factors which result in changes to the venous endothelium and structural wall as well as inflammation. Inflammation, endothelial dysfunction and hyperfiltration or leakage, are commonly observed in diabetes mellitus and cause various diabetic microvascular complications. Both diseases are also influenced by the increased expression of adhesion molecules, chemokines, and cytokines, and are characterized by the presence of vessel hypertension. Consequently, despite differences in etiology, the pathophysiology of both chronic venous disease and diabetic microangiopathy appears to be driven by endothelial dysfunction and inflammation. Treatment strategies should take the co-existence of chronic venous disease and diabetic microangiopathy into account. Compression therapy is recommended in inflammatory conditions that have an edema component as seen in both chronic venous disease and diabetes mellitus. Lifestyle changes like weight loss and exercise, will improve metabolic state and lower inflammation and should be promoted in these patients. Additionally, both patient populations may benefit from venoactive drugs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003102
003      
CZ-PrNML
005      
20220127150654.0
007      
ta
008      
220113s2021 it f 000 0|eng||
009      
AR
024    7_
$a 10.23736/S0392-9590.21.04664-2 $2 doi
035    __
$a (PubMed)34547884
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Gastaldi, Giacomo $u Division of Endocrinology Diabetology Nutrition and Patient Education, Geneva University Hospitals, Geneva, Switzerland
245    10
$a Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities / $c G. Gastaldi, F. Pannier, K. Roztočil, M. Lugli, A. Mansilha, H. Haller, E. Rabe, MJ. VAN Rijn
520    9_
$a Chronic venous disease and diabetes mellitus are highly prevalent and debilitating conditions affecting millions of individuals globally. Although these conditions are typically considered as separate entities, they often co-exist which may be important in both understanding their pathophysiology and determining the best treatment strategy. Diabetes mellitus is twice as common in patients with chronic venous disease compared with the general population. Notably, a large proportion of patients with diabetes mellitus present with venous disorders, although this is often overlooked. The etiology of chronic venous disease is multifactorial, involving hemodynamic, genetic, and environmental factors which result in changes to the venous endothelium and structural wall as well as inflammation. Inflammation, endothelial dysfunction and hyperfiltration or leakage, are commonly observed in diabetes mellitus and cause various diabetic microvascular complications. Both diseases are also influenced by the increased expression of adhesion molecules, chemokines, and cytokines, and are characterized by the presence of vessel hypertension. Consequently, despite differences in etiology, the pathophysiology of both chronic venous disease and diabetic microangiopathy appears to be driven by endothelial dysfunction and inflammation. Treatment strategies should take the co-existence of chronic venous disease and diabetic microangiopathy into account. Compression therapy is recommended in inflammatory conditions that have an edema component as seen in both chronic venous disease and diabetes mellitus. Lifestyle changes like weight loss and exercise, will improve metabolic state and lower inflammation and should be promoted in these patients. Additionally, both patient populations may benefit from venoactive drugs.
650    _2
$a chronická nemoc $7 D002908
650    12
$a diabetes mellitus $7 D003920
650    12
$a diabetické angiopatie $x diagnóza $x epidemiologie $x etiologie $7 D003925
650    _2
$a lidé $7 D006801
650    12
$a hypertenze $7 D006973
650    _2
$a vény $7 D014680
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pannier, Felizitas $u Private Clinic Phlebology and Dermatology, Bonn, Germany $u Department of Dermatology, University of Cologne, Cologne, Germany
700    1_
$a Roztočil, Karel $u Department of Transplantational and Vascular Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Lugli, Marzia $u Unit of Vascular Surgery, Cardiovascular Department, Hesperia Hospital, Modena, Italy
700    1_
$a Mansilha, Armando $u Faculty of Medicine, University of Porto, Porto, Portugal $u Department of Angiology and Vascular Surgery, Hospital de S. João, Porto, Portugal
700    1_
$a Haller, Hermann $u Hannover Medical School, Department of Nephrology and Hypertension, Hannover, Germany
700    1_
$a Rabe, Eberhard $u Department of Dermatology (Emeritus), University of Bonn, Bonn, Germany
700    1_
$a VAN Rijn, Marie Josee $u Department of Vascular Surgery, Erasmus Medical Center, Rotterdam, the Netherlands - m.vanrijn@erasmusmc.nl
773    0_
$w MED00002267 $t International angiology : a journal of the International Union of Angiology $x 1827-1839 $g Roč. 40, č. 6 (2021), s. 457-469
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34547884 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150650 $b ABA008
999    __
$a ok $b bmc $g 1750768 $s 1154251
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 40 $c 6 $d 457-469 $e 20210922 $i 1827-1839 $m International angiology $n Int Angiol $x MED00002267
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...